Bibliography
- Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128(Suppl. 5), S213–S256 (2011)
- Stone NJ, Levy RI, Fredrickson DS, Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation 49(3), 476–488 (1974)
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ 303(6807), 893–896 (1991)
- Claassen L, Henneman L, Kindt I, Marteau TM, Timmermans DR. Perceived risk and representations of cardiovascular disease and preventive behaviour in people diagnosed with familial hypercholesterolemia: a cross-sectional questionnaire study. J. Health Psychol. 15(1), 33–43 (2010)
- Hengstenberg C, Holmer SR, Mayer B et al. Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease. Eur. Heart J. 22(11), 926–933 (2001)
- Resnicow K, Cross D. Are parents' selfreported total cholesterol levels useful in identifying children with hyperlipidemia? An examination of current guideli 7 O'Gorman CS, Higgins MF, O'Neill MB. Systematic review and meta-analysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects. Pediatr. Cardiol. 30(4), 482–489 (2009)
- Wald DS, Bestwick JP, Wald NJ. Childparent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis. BMJ 335(7620), 599 (2007)
- Wald DS, Kasturiratne A, Godoy A et al. Child-parent screening for familial hypercholesterolemia. J. Pediatr. 159(5), 865–867 (2011)
- Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, Scheerder RL, Kastelein JJ. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet 357(9251), 165–168 (2001)
- Marks D, Wonderling D, Thorogood M, Lambert H, Humphries SE, Neil HA. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Health Technol. Assess. 4(29), 1–123 (2000)
- Sattar N, Preiss D, Murray HM et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375(9716), 735–742 (2010).